US Patent Issued to Merrimack Pharmaceuticals on Oct. 7 for "Anti-TNFR2 antibodies and uses thereof" (California, New York, Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,151, issued on Oct. 7, was assigned to Merrimack Pharmaceuticals Inc. (Massachusetts, Morocco).

"Anti-TNFR2 antibodies and uses thereof" was invented by Yu Zhou (San Francisco), James D. Marks (Kensington, Calif.), Marco Muda (New Haven, Conn.), James Frank Sampson (Medford, Mass.), Eric M. Tam (Cooperstown, N.Y.) and Ross Bane Fulton (Southborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are anti-TNFR2 antibodies, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer and autoimmune diseases."

The patent was filed on Feb. 28, 2020,...